UroGen Pharma Ltd.（URGN）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 UroGen Pharma Ltd.（URGN）报告了 46 笔 Form 4 交易（最近一笔 2026-10-09）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-09 | Degnan Chris | Chief Financial Officer | 买入 | 4,483 | $0 |
| 2026-10-09 | Degnan Chris | Chief Financial Officer | 卖出 | 2,202 | $80,791 |
| 2026-09-09 | Schoenberg Mark | Chief Medical Officer | 卖出 | 871 | $37,383 |
| 2026-09-09 | Smith Jason Drew | General Counsel | 买入 | 3,334 | $0 |
| 2026-09-09 | Schoenberg Mark | Chief Medical Officer | 买入 | 1,667 | $0 |
| 2026-09-09 | Smith Jason Drew | General Counsel | 卖出 | 1,519 | $64,618 |
| 2026-08-28 | Robinson James A. Jr. | 董事 | 买入 | 2,000 | $0 |
| 2026-08-24 | Schoenberg Mark | Chief Medical Officer | 卖出 | 60,677 | $2.9M |
| 2026-07-10 | Schoenberg Mark | Chief Medical Officer | 卖出 | 10,000 | $400,000 |
| 2026-06-24 | Schoenberg Mark | Chief Medical Officer | 卖出 | 10,000 | $350,100 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | 买入 | 10,000 | $0 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | 卖出 | 5,222 | $142,561 |
| 2026-05-27 | Robinson James A. Jr. | 董事 | 买入 | 2,000 | $0 |
| 2026-05-11 | Schoenberg Mark | Chief Medical Officer | 卖出 | 10,000 | $300,000 |
| 2026-02-27 | Robinson James A. Jr. | 董事 | 买入 | 2,000 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | 买入 | 5,500 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | 卖出 | 2,654 | $52,257 |
| 2026-02-11 | Smith Jason Drew | General Counsel | 买入 | 3,333 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | 卖出 | 1,608 | $31,662 |
| 2026-02-11 | Smith Jason Drew | General Counsel | 买入 | 6,667 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | 卖出 | 3,217 | $63,343 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | 卖出 | 1,844 | $36,308 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | 卖出 | 1,843 | $36,289 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | 卖出 | 3,686 | $72,577 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | 买入 | 3,333 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-09